Profile of:
Abdellah El Maghraoui
Professor of Rheumatology at the Mohamed V University of Rabat. President of the Moroccan Society of Rheumatology. Former Head of the Rheumatology Department at the Mohamed V Military Teaching Hospital in Rabat, Morocco. Member of the Board of the International Osteoporosis Foundation (IOF). Creator, designer, and webmaster of a medical website dedicated to rheumatology for the continuous training of healthcare professionals: www.rhumato.info (averaging 2000 unique visitors/day). Author of seven books, two book chapters and of more than 141 Scopus indexed articles and 128 Pubmed indexed articles (https://www.ncbi.nlm.nih.gov/myncbi/abdellah.elmaghraoui.1/bibliography/public/): 6280 Google Scholar citations ; H-index : 40 ; i10-index : 102
Full name: Abdellah El Maghraoui
Current country: Morocco
Membership level: Associate
Type of membership: Member
Number of publications: 10
Factors Determining the Switch of the First Biological Treatment in Spondyloarthritis: Data from the RBSMR Registry (2026)
https://pubmed.ncbi.nlm.nih.gov/41568504/
Real-world evidence of biological treatments in rheumatoid arthritis and spondyloarthritis in Morocco: results of the RBSMR registry (2025)
https://pubmed.ncbi.nlm.nih.gov/40426283/
Psoriatic Arthritis Characteristics and Comorbidities in North Africa: Results of a Multicenter Retrospective Study (2025)
https://pubmed.ncbi.nlm.nih.gov/41459256/
Recommendations of the Moroccan Society of Rheumatology (SMR) for Diagnostic Management of Spondyloarthritis (SpA) and Psoriatic Arthritis (PsA) (2023)
https://pubmed.ncbi.nlm.nih.gov/37941856/
Recommendations of the Moroccan Society of Rheumatology (SMR) for the Therapeutic Management of Spondyloarthritis (SpA) including Psoriatic Arthritis (PsA) (2023)
https://pubmed.ncbi.nlm.nih.gov/37654637/
Characteristics of Late-Onset Spondyloarthritis: Data from the Moroccan Registry of Biological Therapies in Rheumatic Diseases (2023)
https://pubmed.ncbi.nlm.nih.gov/37273389/
Discontinuation of biologic therapy in patients with rheumatoid arthritis and ankylosing spondylitis: analysis from multicenter cohort study (2023)
https://pubmed.ncbi.nlm.nih.gov/36334121/
Extra-Articular Manifestations in Patients with Ankylosing Spondylitis: Baseline Characteristics from the RBSMR Study (2022)
https://pubmed.ncbi.nlm.nih.gov/36531422/
Prevalence of latent tuberculosis before biotherapy initiation in rheumatoid arthritis and spondyloarthritis: data from the Moroccan biotherapy registry (2021)
https://pubmed.ncbi.nlm.nih.gov/34173843/
Reproducibility of total and regional body composition using dual-energy X-ray absorptiometry in rheumatoid arthritis and ankylosing spondylitis (2021)
https://pubmed.ncbi.nlm.nih.gov/33386877/